March 06, 2015 4:45 AM ET

Biotechnology

Company Overview of Dance BioPharm Inc.

Company Overview

Dance Biopharm Inc., a development stage biopharmaceutical company, focuses on the development of inhaled insulin products for the treatment of diabetes worldwide. Its lead product candidate includes Dance 501, a drug/device combination product to deliver a high purity liquid insulin formulation through a small handheld electronic inhaler that has completed Phase II clinical trials in adult patients with type 2 diabetes. The company was formerly known as Dance Pharmaceuticals, Inc. and changed its name to Dance Biopharm Inc. in February 2013. Dance Biopharm Inc. was founded in 2009 and is based in Brisbane, California.

150 North Hill Drive

Suite 24

Brisbane, CA 94005

United States

Founded in 2009

17 Employees

Phone:

415-369-9415

Key Executives for Dance BioPharm Inc.

Chairman, Chief Executive Officer and Founder
Age: 66
President and Director
Age: 54
Chief Financial Officer, Principal Accounting Officer and Vice President of Administration
Age: 43
Executive Vice President of Operations and Quality
Age: 61
Chief Business Officer and Director
Age: 49
Compensation as of Fiscal Year 2014.

Dance BioPharm Inc. Key Developments

Dance Biopharm Inc. Appoints Dr. Tyler Martin to the Position of President and Director

Dance Biopharm Inc. announced the appointment of J. Tyler Martin, M.D., to the newly created position of president. Dr. Martin has also been appointed to the board of directors. He brings more than 20 years of experience in the biotechnology industry to Dance, where he oversees company operations, reporting to Dr. John Patton, CEO. Dr. Martin's most recent corporate position was with Dynavax Technologies, where he joined as chief medical officer in 2009 and then became president in 2010 and a member of the board of directors. He served as president until 2013 when he left to pursue a position as founder and CEO of Great Plains Biotechnology. He also serves as a director of Adjuvance Technologies.

Dance BioPharm Inc. expected to report Fiscal Year 2014 results on March 5, 2015. This event was calculated by Capital IQ (Created on October 10, 2014).

Dance BioPharm Inc. expected to report Fiscal Year 2014 results on March 5, 2015. This event was calculated by Capital IQ (Created on October 10, 2014).

Similar Private Companies By Industry

Company Name Region
Pel-Freez Arkansas, LLC United States
Hemodyne, Inc. United States
Restoragen Inc. United States
Talon Therapeutics, Inc. United States
LipoScience, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
December 19, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Dance BioPharm Inc., please visit www.dancebiopharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.